Andrew Goldsweig to United States Food and Drug Administration
This is a "connection" page, showing publications Andrew Goldsweig has written about United States Food and Drug Administration.
Connection Strength
0.041
-
Mahabir CA, DeFilippis EM, Aggarwal S, Bath A, Qamar A, Patel NK, Goldsweig AM, Vaduganathan M. The First 4 Years of Postmarketing Safety Surveillance Related to the MitraClip Device: A United States Food and Drug Administration MAUDE Experience. J Invasive Cardiol. 2020 05; 32(5):E130-E132.
Score: 0.041